Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
New England Journal of Medicine · 06.11.2025 · 393 (18) · 1796-1806
DOI: 10.1056/nejmoa2511774 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 06.11.2025. Verfasst von Sean Wharton und 13 weiteren Autor:innen. Beteiligte Einrichtung: McMaster University, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Weight Loss. Die Arbeit wurde bisher 209-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- McMaster University, Hamilton, ON, Canada.
- York University, Toronto.
- Wharton Weight Management Clinic, Burlington, ON, Canada.
- Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medicine, New York.
- Eli Lilly, Indianapolis.
- Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, Saudi Arabia.
ORCID-Profile: Bruno Halpern
Förderung
- Eli Lilly and Company
Zitieren
APA
Wharton, S., Aronne, L. J., Stefanski, A., Alfaris, N. F., Ciudin, A., Yokote, K., Halpern, B., Shukla, A. P., Zhou, C., Macpherson, L., Allen, S. E., Ahmad, N. N., Klise, S. R., & ATTAIN-1 Trial Investigators (2025). Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. New England Journal of Medicine, 393(18), 1796-1806. https://doi.org/10.1056/nejmoa2511774
Vancouver
Wharton S, Aronne LJ, Stefanski A, Alfaris NF, Ciudin A, Yokote K, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. New England Journal of Medicine. 2025;393(18):1796-1806. doi:10.1056/nejmoa2511774
BibTeX
@article{Wharton2025,
author = {Wharton, Sean and Aronne, Louis J and Stefanski, Adam and Alfaris, Nasreen F and Ciudin, Andreea and Yokote, Koutaro and Halpern, Bruno and Shukla, Alpana P and Zhou, Chunmei and Macpherson, Lisa and Allen, Sheryl E and Ahmad, Nadia N and Klise, Suzanne R and ATTAIN-1 Trial Investigators, ATTAIN-1 Trial Investigators},
title = {Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {18},
pages = {1796--1806},
doi = {10.1056/nejmoa2511774}
}
EUVIMED